Catalyst Pharmaceuticals (CPRX) Enterprise Value (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Enterprise Value of -$755.9 million for Q1 2026, down 30.17% year-on-year from -$1.1 billion in Q1 2025, and down 6.58% on a QoQ basis from -$709.2 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Enterprise Value data on file, last reported at -$755.9 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 30.17% year-over-year to -$755.9 million; the trailing twelve-month figure through Mar 2026 stood at -$755.9 million (down 30.17% YoY), and the FY2025 full-year result was -$709.2 million, down 37.02% from the prior year.
- Enterprise Value for Q1 2026 stood at -$755.9 million, down from -$709.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$121.0 million in Q3 2023 and bottomed at -$755.9 million in Q1 2026.
- The 5-year median for Enterprise Value is -$310.4 million (2024), against an average of -$387.8 million.
- The widest annual swing landed in 2023, when Enterprise Value soared 53.87%; it then tumbled 276.03% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$298.4 million in 2022, then jumped by 53.87% to -$137.6 million in 2023, then sank by 276.03% to -$517.6 million in 2024, then plunged by 37.02% to -$709.2 million in 2025, then fell by 6.58% to -$755.9 million in 2026.
- The last three Enterprise Value figures came in at -$755.9 million (Q1 2026), -$709.2 million (Q4 2025), and -$689.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -755.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -755.86 Mn |
| Dec 31, 2025 | -709.17 Mn |
| Sep 30, 2025 | -689.89 Mn |
| Jun 30, 2025 | -652.80 Mn |
| Mar 31, 2025 | -580.66 Mn |
| Dec 31, 2024 | -517.55 Mn |
| Sep 30, 2024 | -442.33 Mn |
| Jun 30, 2024 | -375.69 Mn |
| Mar 31, 2024 | -310.41 Mn |
| Dec 31, 2023 | -137.64 Mn |
| Sep 30, 2023 | -120.97 Mn |
| Jun 30, 2023 | -178.79 Mn |
| Mar 31, 2023 | -148.25 Mn |
| Dec 31, 2022 | -298.40 Mn |
| Sep 30, 2022 | -256.07 Mn |
| Jun 30, 2022 | -220.79 Mn |
| Mar 31, 2022 | -197.80 Mn |
| Dec 31, 2021 | -191.27 Mn |
| Sep 30, 2021 | -174.79 Mn |
| Jun 30, 2021 | -155.28 Mn |
| Mar 31, 2021 | -143.30 Mn |
| Dec 31, 2020 | -140.28 Mn |
| Sep 30, 2020 | -127.11 Mn |
| Jun 30, 2020 | -115.05 Mn |
| Mar 31, 2020 | -101.75 Mn |
| Dec 31, 2019 | -94.52 Mn |
| Sep 30, 2019 | -76.54 Mn |
| Jun 30, 2019 | -59.92 Mn |
| Mar 31, 2019 | -45.63 Mn |
| Dec 31, 2018 | -53.48 Mn |
| Sep 30, 2018 | -61.66 Mn |
| Jun 30, 2018 | -68.41 Mn |
| Mar 31, 2018 | -77.94 Mn |
| Dec 31, 2017 | -84.01 Mn |
| Sep 30, 2017 | -33.91 Mn |
| Jun 30, 2017 | -35.13 Mn |
| Mar 31, 2017 | -36.53 Mn |
| Dec 31, 2016 | -40.41 Mn |
| Sep 30, 2016 | -18.21 Mn |
| Jun 30, 2016 | -45.25 Mn |
| Mar 31, 2016 | -25.95 Mn |
| Dec 31, 2015 | -31.95 Mn |
| Sep 30, 2015 | -36.47 Mn |
| Jun 30, 2015 | -40.94 Mn |
| Mar 31, 2015 | -45.04 Mn |
| Dec 31, 2014 | -35.56 Mn |
| Sep 30, 2014 | -37.73 Mn |
| Jun 30, 2014 | -18.52 Mn |
| Mar 31, 2014 | -4.79 Mn |
| Dec 31, 2013 | -19.70 Mn |
| Sep 30, 2013 | -23.64 Mn |
| Jun 30, 2013 | -7.36 Mn |
| Mar 31, 2013 | -646,045.00 |
| Dec 31, 2012 | -8.91 Mn |
| Sep 30, 2012 | -11.97 Mn |
| Jun 30, 2012 | -7.51 Mn |
| Mar 31, 2012 | -4.72 Mn |
| Dec 31, 2011 | -6.03 Mn |
| Sep 30, 2011 | -4.16 Mn |
| Jun 30, 2011 | -5.41 Mn |
| Mar 31, 2011 | -6.87 Mn |
| Dec 31, 2010 | -5.48 Mn |
| Sep 30, 2010 | -6.25 Mn |